235 related articles for article (PubMed ID: 22753445)
41. Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.
Cruz F; Herschorn S; Aliotta P; Brin M; Thompson C; Lam W; Daniell G; Heesakkers J; Haag-Molkenteller C
Eur Urol; 2011 Oct; 60(4):742-50. PubMed ID: 21798658
[TBL] [Abstract][Full Text] [Related]
42. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis.
Giovannelli M; Borriello G; Castri P; Prosperini L; Pozzilli C
Clin Rehabil; 2007 Apr; 21(4):331-7. PubMed ID: 17613573
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of intra-articular botulinum toxin type A in painful knee osteoarthritis: a pilot study.
Boon AJ; Smith J; Dahm DL; Sorenson EJ; Larson DR; Fitz-Gibbon PD; Dykstra DD; Singh JA
PM R; 2010 Apr; 2(4):268-76. PubMed ID: 20430328
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of a novel botulinum toxin type A product for the treatment of moderate to severe glabellar lines: a randomized, double-blind, active-controlled multicenter study.
Won CH; Lee HM; Lee WS; Kang H; Kim BJ; Kim WS; Lee JH; Lee DH; Huh CH
Dermatol Surg; 2013 Jan; 39(1 Pt 2):171-8. PubMed ID: 23301821
[TBL] [Abstract][Full Text] [Related]
45. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity.
Kanovský P; Slawek J; Denes Z; Platz T; Sassin I; Comes G; Grafe S
Clin Neuropharmacol; 2009; 32(5):259-65. PubMed ID: 19644361
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of botulinum toxin A in treatment of tinnitus.
Stidham KR; Solomon PH; Roberson JB
Otolaryngol Head Neck Surg; 2005 Jun; 132(6):883-9. PubMed ID: 15944559
[TBL] [Abstract][Full Text] [Related]
47. [Treatment of focal upper limb spasticity with botulinum toxin after stroke. Interest of an individual approach].
Luauté J; Landrault E; Jacquin-Courtois S; Mertens P; Rode G; Boisson D
Ann Readapt Med Phys; 2004 Oct; 47(8):555-62. PubMed ID: 15465160
[TBL] [Abstract][Full Text] [Related]
48. Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial.
Rajan R; Srivastava AK; Anandapadmanabhan R; Saini A; Upadhyay A; Gupta A; Vishnu VY; Pandit AK; Vibha D; Singh MB; Bhatia R; Goyal V; Dwivedi SN; Srivastava P; Prasad K
JAMA Neurol; 2021 Mar; 78(3):302-311. PubMed ID: 33346814
[TBL] [Abstract][Full Text] [Related]
49. Botulinum toxin treatment of essential head tremor.
Pahwa R; Busenbark K; Swanson-Hyland EF; Dubinsky RM; Hubble JP; Gray C; Koller WC
Neurology; 1995 Apr; 45(4):822-4. PubMed ID: 7723978
[TBL] [Abstract][Full Text] [Related]
50. Treatment with Botulinum Neurotoxin Improves Activities of Daily Living and Quality of Life in Patients with Upper Limb Tremor.
Kreisler A; Bouchain B; Defebvre L; Krystkowiak P
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31413896
[TBL] [Abstract][Full Text] [Related]
51. Treatment of proximal upper limb tremor with botulinum toxin therapy.
Kim SD; Yiannikas C; Mahant N; Vucic S; Fung VS
Mov Disord; 2014 May; 29(6):835-8. PubMed ID: 24519658
[TBL] [Abstract][Full Text] [Related]
52. Botulinum toxin in essential hand tremor - A randomized double-blind placebo-controlled study with customized injection approach.
Mittal SO; Machado D; Richardson D; Dubey D; Jabbari B
Parkinsonism Relat Disord; 2018 Nov; 56():65-69. PubMed ID: 29929813
[TBL] [Abstract][Full Text] [Related]
53. Treatment of lateral epicondylitis with botulinum toxin: a randomized, double-blind, placebo-controlled trial.
Wong SM; Hui AC; Tong PY; Poon DW; Yu E; Wong LK
Ann Intern Med; 2005 Dec; 143(11):793-7. PubMed ID: 16330790
[TBL] [Abstract][Full Text] [Related]
54. The efficacy of primidone in reducing severe cerebellar tremors in patients with multiple sclerosis.
Naderi F; Javadi SA; Motamedi M; Sahraian MA
Clin Neuropharmacol; 2012; 35(5):224-6. PubMed ID: 22821064
[TBL] [Abstract][Full Text] [Related]
55. Botulinum toxin A in postherpetic neuralgia: a parallel, randomized, double-blind, single-dose, placebo-controlled trial.
Apalla Z; Sotiriou E; Lallas A; Lazaridou E; Ioannides D
Clin J Pain; 2013 Oct; 29(10):857-64. PubMed ID: 23370074
[TBL] [Abstract][Full Text] [Related]
56. A new paradigm for the management of essential vocal tremor with botulinum toxin.
Gurey LE; Sinclair CF; Blitzer A
Laryngoscope; 2013 Oct; 123(10):2497-501. PubMed ID: 23553653
[TBL] [Abstract][Full Text] [Related]
57. Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study.
Jog M; Lee J; Scheschonka A; Chen R; Ismail F; Boulias C; Hobson D; King D; Althaus M; Simon O; Dersch H; Frucht S; Simpson DM
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419261
[TBL] [Abstract][Full Text] [Related]
58. Immunoresistance in cervical dystonia patients after treatment with abobotulinumtoxinA.
Coleman C; Hubble J; Schwab J; Beffy JL; Picaut P; Morte C
Int J Neurosci; 2012 Jul; 122(7):358-62. PubMed ID: 22356470
[TBL] [Abstract][Full Text] [Related]
59. Botulinum toxin A in non-dystonic tremors.
Henderson JM; Ghika JA; Van Melle G; Haller E; Einstein R
Eur Neurol; 1996; 36(1):29-35. PubMed ID: 8719647
[TBL] [Abstract][Full Text] [Related]
60. Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.
Samotus O; Lee J; Jog M
PLoS One; 2017; 12(6):e0178670. PubMed ID: 28586370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
